Why Institutions Do not Participate in Ovarian Cancer Trials – Results from a Survey in Germany

Publisher： Karger

E-ISSN： 2296-5262|28|1|13-17

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.1, 2004-12, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9)

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 351-358

Karger

Access to resources Recommend Favorite

Treatment of Cancer-Associated Anaemia: Results from a Two-Day Cross-Sectional Survey in Germany

By  

Oncology Research and Treatment, Vol. 36, Iss. 5, 2013-04 ,pp. : 266-272

Karger

Access to resources Recommend Favorite

Why do students participate in medical education?

By  

THE CLINICAL TEACHER (ELECTRONIC), Vol. 12, Iss. 1, 2015-02 ,pp. : 46-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

Treatment of Elderly Ovarian Cancer Patients in the Context of Controlled Clinical Trials: A Joint Analysis of the AGO Germany Experience

By  

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 76-81

Karger

Access to resources Recommend Favorite